A novel, pharmacist-led strategy to reduce the prescribing of benzodiazepines in Paisley

Pharmaceutical Journal

Volumn 276, Issue 7386, 2006, Pages 136-138

  Towle, Ian ^a,b   Adams, Joan ^a  

^a Psychological Services   (United Kingdom)

^b Primary Care Services   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHLORDIAZEPOXIDE; DIAZEPAM; NITRAZEPAM;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; ANXIETY DISORDER; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; INSOMNIA; INTERDISCIPLINARY COMMUNICATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; PHARMACIST; POLICY; PRESCRIPTION; REVIEW; TEAMWORK; UNITED KINGDOM;

EID: 33144479339     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. British National Formulary. Edition 49. London: Royal Pharmaceutical Society of Great Britain and British Medical Association; 2005. pp173-4.
2. Ashton CH. Toxicity and adverse consequences of benzodiazepine use. Psychiatric Annals 1995;25:158-65.
3. Cormack MA, Sweeney KG, Hughes-Jones H, Foot GA. Evaluation of an easy, cost effective strategy for cutting benzodiazopine use in general practice. British Journal of General Practice 1994;44:5-8.
4. Wylie RM. Reducing benzodiazepine usage. British Journal of General Practice 1995;45:327.
5. Heather N, Bowie A, Ashton H, McAvoy B, Spencer I, Brodie J et al. Randomised controlled trial of two brief interventions against long term benzodiazepine use: outcome of intervention. Addiction Research and Theory 2004;12:141-54.
6. Morgan JD, Wright DJ, Chrystyn H. Pharmacoeconomic evaluation of a patent education letter aimed at reducing longterm prescribing of benzodiazepines. Pharmacy World and Science 2002;24:231-5.
7. Berry S. Ways to reduce the use of anxiolytic and hypnotic drugs in care. Prescribing and Medicines Management 2002;(March/April):11-12.
8. Andalo D. Pharmacists and GPs work together to support benzodiazepine withdrawal. Prescribing and Medicines Management 2004;(March):1.
9. Orwin M, Williams H. Benzodiazepine withdrawal at a pharmacy technician-led clinic. Prescribing and Medicines Management 2005;(March):3.
10. Zermanski AG. Who controls repeats? British Journal of General Practice 1996;46:643-7.
11. Lader M.H. Limitations on the use of benzodiazopines in anxiety and insomnia: are they justified? European Neuropsychopharmacology 1999;(9 December[Suppl ]): S399-405.
12. National Prescribing Centre. Benzodiazepines and newer hypnotics. MeReC Bulletin 2005;15:17-20.